Table 2.
Potential risks/negative consequences | Participants’ code
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | |
Adverse events | • | • | • | • | • | • | • | • | • | • | |||||
Vomiting | • | ||||||||||||||
Gastric problems/ulcer | • | • | |||||||||||||
Bleeding from GIT | • | ||||||||||||||
Bleeding | • | • | • | • | |||||||||||
Respiratory depression | • | ||||||||||||||
Allergies | • | • | • | • | • | • | |||||||||
Interactions | • | • | • | • | • | ||||||||||
Overdose | • | • | |||||||||||||
Drug abuse | • | • | |||||||||||||
Addiction | • | • | • | • | • | ||||||||||
Inappropriate dosage | • | • | • | ||||||||||||
Inappropriate analgesic/contraindications | • | • | • | ||||||||||||
Polypragmasy | • | ||||||||||||||
Activation of comorbidity | • | ||||||||||||||
Delay in seeking professional help | • | ||||||||||||||
Expiration date | • |
Abbreviation: GIT, gastrointestinal tract.